Statements & Press Releases

Jul 8, 2022

PUTT: GOVERNOR DESANTIS’ BOLD STAND FOR DRUG PRICE TRANSPARENCY PROVES STATES CAN AND SHOULD LEAD THE WAY ON PBM REFORM

"With the signing of this new executive order, there’s no longer an excuse for states to bend to the will of a few Fortune 15 pharmacy middlemen whose job is to literally ensure profits are prioritized over patient care."

PUTT: GOVERNOR DESANTIS’ BOLD STAND FOR DRUG PRICE TRANSPARENCY PROVES STATES CAN AND SHOULD LEAD THE WAY ON PBM REFORM

Jun 17, 2022

PUTT APPLAUDS FTC VOTE TO LAUNCH PBM STUDY AND FTC FOR ISSUING ENFORCEMENT POLICY STATEMENT FOLLOWING INSULIN HEARING

New Policy Statement Outlines a Plan to End PBM Practice of Using Higher-Priced Drug Rebates to Exclude Lower-Cost Drugs, Including in the Case of Insulin

PUTT APPLAUDS FTC VOTE TO LAUNCH PBM STUDY AND FTC FOR ISSUING ENFORCEMENT POLICY STATEMENT FOLLOWING INSULIN HEARING

Jun 8, 2022

FTC Launches 6(b) Study of PBMs, Votes to Order the 6 Largest PBMs to Turn Over Documents and Data as Part of Study

The PUTT Members Behind the FTC's Vote to Investigate PBMs

FTC Launches 6(b) Study of PBMs, Votes to Order the 6 Largest PBMs to Turn Over Documents and Data as Part of Study

Apr 20, 2022

Millions Overpaid for Prescriptions in Secretive Scheme, Lawsuit Filed by Attorney General Jeff Landry to Recover Inflated Charges

Unregulated middlemen, cloaked in secrecy, drive up their own profits at the expense of Louisiana citizens

Millions Overpaid for Prescriptions in Secretive Scheme, Lawsuit Filed by Attorney General Jeff Landry  to Recover Inflated Charges

Apr 20, 2022

PUTT Sign-On Letter to the FTC Regarding PBM Practices and Their Harm to the Healthcare System

How Pharmacy Benefit Managers are Gaming the System to Their Advantage, Creating Obstacles for Patients and Creating a Real and Present Danger to non-PBM owned Pharmacies

PUTT Sign-On Letter to the FTC Regarding PBM Practices and Their Harm to the Healthcare System

Mar 7, 2022

PUTT Statement to CMS Regarding the Medicare DIR Fee Proposed Rule Change

RE: Medicare Program; Contract Year 2023 Policy and Technical Changes to the Medicare
Advantage and Medicare Prescription Drug Benefit Programs (CMS-4192-P)

PUTT Statement to CMS Regarding the Medicare DIR Fee Proposed Rule Change

Feb 18, 2022

PUTT STATEMENT ON THE FAILURE OF THE FTC TO AUTHORIZE STUDY OF PBM-PHARMACY RELATIONSHIP FOLLOWING IMPASSIONED PUBLIC HEARING

Commissioners Wilson and Phillips: Your Actions Lead Us to Wonder if You Participated in the Hearing with an Open Mind, or if You are Protecting the Rights of Modern-Day Robber Barons

PUTT STATEMENT ON THE FAILURE OF THE FTC TO AUTHORIZE STUDY OF PBM-PHARMACY RELATIONSHIP FOLLOWING IMPASSIONED PUBLIC HEARING

Dec 31, 2021

PUTT STATEMENT TO NEW YORK GOVERNOR KATHY HOCHUL: PHARMACY PAYMENT PARITY BILL VETO IS A VOTE AGAINST YOUR PEOPLE

PUTT STATEMENT TO NEW YORK GOVERNOR KATHY HOCHUL:  PHARMACY PAYMENT PARITY BILL VETO IS A VOTE AGAINST YOUR PEOPLE